| Primary |
| Essential Thrombocythaemia |
17.8% |
| Polycythaemia Vera |
11.8% |
| Chronic Myeloid Leukaemia |
11.3% |
| Acute Myeloid Leukaemia |
6.6% |
| Thrombocytosis |
6.0% |
| Thrombocytopenia |
5.1% |
| Platelet Count Increased |
4.9% |
| Polycythaemia |
4.5% |
| Breast Cancer |
4.1% |
| Sickle Cell Anaemia |
3.6% |
| Myelofibrosis |
3.4% |
| Hypertension |
3.0% |
| Myelodysplastic Syndrome |
3.0% |
| Bile Duct Cancer |
2.6% |
| Diabetes Mellitus |
2.6% |
| Myeloproliferative Disorder |
2.6% |
| Psoriasis |
2.1% |
| Thrombocythaemia |
2.1% |
| Bronchopulmonary Aspergillosis |
1.5% |
| Atrial Fibrillation |
1.3% |
|
| Pyrexia |
11.9% |
| Interstitial Lung Disease |
9.8% |
| Skin Ulcer |
7.7% |
| Vomiting |
6.3% |
| Haemorrhage |
5.6% |
| Renal Failure |
5.6% |
| Death |
4.9% |
| Squamous Cell Carcinoma |
4.9% |
| Thrombocytopenia |
4.9% |
| Pancytopenia |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Anaemia |
3.5% |
| Cerebrovascular Accident |
3.5% |
| Macrocytosis |
3.5% |
| Malignant Neoplasm Progression |
3.5% |
| Platelet Count Increased |
3.5% |
| Pneumonia |
3.5% |
| Pregnancy |
3.5% |
| Back Pain |
2.8% |
| Breast Cancer |
2.8% |
|
| Secondary |
| Chronic Myeloid Leukaemia |
14.7% |
| Product Used For Unknown Indication |
11.7% |
| Acute Myeloid Leukaemia |
11.5% |
| Bronchopulmonary Aspergillosis |
9.5% |
| Essential Thrombocythaemia |
8.2% |
| Langerhans' Cell Granulomatosis |
7.7% |
| Drug Use For Unknown Indication |
4.1% |
| Myelodysplastic Syndrome |
3.7% |
| Hypertension |
3.1% |
| Tongue Neoplasm Malignant Stage Unspecified |
3.1% |
| Glioblastoma Multiforme |
3.0% |
| Breast Cancer |
2.9% |
| Head And Neck Cancer |
2.4% |
| Thrombocytopenia |
2.4% |
| Pyrexia |
2.3% |
| Hypopharyngeal Cancer |
2.2% |
| Polycythaemia Vera |
2.2% |
| Iron Overload |
1.9% |
| Prophylaxis |
1.8% |
| Acute Leukaemia |
1.7% |
|
| Pyrexia |
13.0% |
| Vomiting |
8.7% |
| White Blood Cell Count Increased |
8.7% |
| Pneumonia |
7.2% |
| White Blood Cell Count Decreased |
7.2% |
| Thrombocytopenia |
6.5% |
| Ventricular Fibrillation |
5.8% |
| Pancytopenia |
5.1% |
| Anaemia |
3.6% |
| Splenomegaly |
3.6% |
| Staphylococcal Infection |
3.6% |
| Viral Infection |
3.6% |
| Cerebellar Syndrome |
2.9% |
| Death |
2.9% |
| Diet Refusal |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Lung Infection |
2.9% |
| Rash Maculo-papular |
2.9% |
| Renal Failure Acute |
2.9% |
| Skin Disorder |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.6% |
| Chronic Myeloid Leukaemia |
16.0% |
| Product Used For Unknown Indication |
16.0% |
| Acute Myeloid Leukaemia |
5.5% |
| Pain |
4.9% |
| Hypertension |
4.6% |
| Prophylaxis |
4.6% |
| Myelodysplastic Syndrome |
4.4% |
| Sickle Cell Anaemia |
4.4% |
| Iron Overload |
3.6% |
| Diabetes Mellitus |
3.5% |
| Myelofibrosis |
3.0% |
| Essential Thrombocythaemia |
2.6% |
| Polycythaemia Vera |
1.9% |
| Unevaluable Event |
1.7% |
| Cardiac Failure |
1.7% |
| Osteoporosis |
1.4% |
| Nausea |
1.3% |
| Myeloproliferative Disorder |
1.2% |
| Atrial Fibrillation |
1.1% |
|
| Vomiting |
14.5% |
| White Blood Cell Count Decreased |
9.6% |
| Thrombocytopenia |
8.6% |
| Weight Decreased |
8.3% |
| White Blood Cell Count Increased |
8.3% |
| Renal Failure |
4.7% |
| Sickle Cell Anaemia With Crisis |
4.4% |
| Rash |
4.2% |
| Death |
3.9% |
| Electrocardiogram Qt Prolonged |
3.7% |
| Renal Failure Acute |
3.7% |
| Pyrexia |
3.4% |
| Pneumonia |
3.2% |
| Urinary Tract Infection |
3.2% |
| Diarrhoea |
2.9% |
| Nausea |
2.9% |
| Weight Increased |
2.9% |
| Respiratory Failure |
2.7% |
| Acute Myeloid Leukaemia |
2.5% |
| Pain |
2.5% |
|
| Interacting |
| Bile Duct Cancer |
63.2% |
| Essential Thrombocythaemia |
26.3% |
| Herpes Zoster |
5.3% |
| Pain |
5.3% |
|
| Pancytopenia |
60.0% |
| Drug Interaction |
20.0% |
| Pain |
20.0% |
|
